185 related articles for article (PubMed ID: 8995306)
1. Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity.
Lima WF; Brown-Driver V; Fox M; Hanecak R; Bruice TW
J Biol Chem; 1997 Jan; 272(1):626-38. PubMed ID: 8995306
[TBL] [Abstract][Full Text] [Related]
2. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
Bruice TW; Lima WF
Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes.
Hanecak R; Brown-Driver V; Fox MC; Azad RF; Furusako S; Nozaki C; Ford C; Sasmor H; Anderson KP
J Virol; 1996 Aug; 70(8):5203-12. PubMed ID: 8764029
[TBL] [Abstract][Full Text] [Related]
4. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
Lima WF; Crooke ST
Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.
Brown-Driver V; Eto T; Lesnik E; Anderson KP; Hanecak RC
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):145-54. PubMed ID: 10355821
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence.
Wakita T; Wands JR
J Biol Chem; 1994 May; 269(19):14205-10. PubMed ID: 8188703
[TBL] [Abstract][Full Text] [Related]
7. RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications.
Mutso M; Nikonov A; Pihlak A; Žusinaite E; Viru L; Selyutina A; Reintamm T; Kelve M; Saarma M; Karelson M; Merits A
PLoS One; 2015; 10(6):e0128686. PubMed ID: 26039055
[TBL] [Abstract][Full Text] [Related]
8. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay.
Seki M; Honda Y
J Biochem; 1995 Dec; 118(6):1199-204. PubMed ID: 8720135
[TBL] [Abstract][Full Text] [Related]
9. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression.
Monia BP; Lesnik EA; Gonzalez C; Lima WF; McGee D; Guinosso CJ; Kawasaki AM; Cook PD; Freier SM
J Biol Chem; 1993 Jul; 268(19):14514-22. PubMed ID: 8390996
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
Fukuma T; Walton CM; Wu CH; Wu GY
Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739
[TBL] [Abstract][Full Text] [Related]
13. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW
Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of dengue virus by novel, modified antisense oligonucleotides.
Raviprakash K; Liu K; Matteucci M; Wagner R; Riffenburgh R; Carl M
J Virol; 1995 Jan; 69(1):69-74. PubMed ID: 7983769
[TBL] [Abstract][Full Text] [Related]
15. Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation.
Alt M; Renz R; Hofschneider PH; Caselmann WH
Arch Virol; 1997; 142(3):589-99. PubMed ID: 9349305
[TBL] [Abstract][Full Text] [Related]
16. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets.
Kawasaki AM; Casper MD; Freier SM; Lesnik EA; Zounes MC; Cummins LL; Gonzalez C; Cook PD
J Med Chem; 1993 Apr; 36(7):831-41. PubMed ID: 8464037
[TBL] [Abstract][Full Text] [Related]
17. How RNase HI (Escherichia coli) promoted site-selective hydrolysis works on RNA in duplex with carba-LNA and LNA substituted antisense strands in an antisense strategy context?
Plashkevych O; Li Q; Chattopadhyaya J
Mol Biosyst; 2017 May; 13(5):921-938. PubMed ID: 28352859
[TBL] [Abstract][Full Text] [Related]
18. Design, biochemical, biophysical and biological properties of cooperative antisense oligonucleotides.
Kandimalla ER; Manning A; Lathan C; Byrn RA; Agrawal S
Nucleic Acids Res; 1995 Sep; 23(17):3578-84. PubMed ID: 7567472
[TBL] [Abstract][Full Text] [Related]
19. The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity.
Lima WF; Mohan V; Crooke ST
J Biol Chem; 1997 Jul; 272(29):18191-9. PubMed ID: 9218455
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.
Vidalin O; Major ME; Rayner B; Imbach JL; Trépo C; Inchauspé G
Antimicrob Agents Chemother; 1996 Oct; 40(10):2337-44. PubMed ID: 8891141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
